We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Rapid Stain Visualizes Sexually Transmitted Parasite

By LabMedica International staff writers
Posted on 06 Oct 2010
The protozoan parasite that causes trichomoniasis can be stained easily and rapidly with Modified Field's Stain (MF). More...


Trichomonas vaginalis, a flagellate protozoan parasite commonly found in the human genitourinary tract, is transmitted primarily by sexual intercourse. Diagnosis is usually by in vitro culture method and staining with either Giemsa stain or Gram stain.

A more rapid staining technique facilitates identification especially made from vaginal swabs. The three staining methods, Giemsa, Gram and MF, were compared at the Faculty of Medicine, University of Malaya (Kuala Lumpur, Malaysia). Sediment from both axenic and xenic cultures was used to make thin smears on clean glass slides for staining. Sediment from xenic cultures was also inserted into freshly collected urine samples and subsequently centrifuged. Smears were also made from spiked urine samples for staining purposes. The smears from the sediment at the bottom of culture tubes were performed in triplicates. Urine samples were obtained from the patients providing vaginal swabs, which were subsequently centrifuged.

The Giemsa stain took 20 minutes, but was it found to be tedious in preparation time, although provided good contrast for morphological identification of the parasite. The Gram stain took only five minutes, but was the poorest with no contrast for parasite identification. The Modified Field stain was very rapid, taking only 20 seconds and it confers sharper staining contrast, which differentiates the nucleus and the cytoplasm of the organism.

The authors concluded that for the first time a rapid staining method using MF stain facilitates the identification of T. vaginalis. The protocol is simple and rapid but also the contrast showing nucleus, cytoplasm, vacuoles, and flagella was clearly visible and is equal if not better than Giemsa. MF staining offers a rapid staining protocol in laboratories and is recommended that it be used widely. The only observation to take note is that staining must be done on slides within 12 hours after smearing as the contrast becomes lesser when the duration of fixing and staining increases more than 12 hours. The results of the study were published in the October 2010 issue of Diagnostic Microbiology and Infectious Disease. It has been estimated that more than 170 million people worldwide are infected with T. vaginalis per year.

Related Links:

University of Malaya




Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Rheumatoid Factors (RF) Test
Rheumatoid Factors (RF)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.